Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy

Clinical trial NCT06078839 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06078839
Sponsor: Xu Li
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sepsis Sepsis-induced Coagulopathy Nafamostat Mesilate

Start date: 2023-10-01
Primary completion: 2026-10-01
Enrollment: 778

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.